Original Article
Predictive model based on folate receptor-positive circulating tumor cells in neoadjuvant immunochemotherapy for esophageal cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:45
.
(30 April 2026)
Neoadjuvant adebrelimab combined with triplet chemotherapy for locally advanced resectable adenocarcinoma of esophagogastric junction: a prospective, single-arm, phase II feasibility and safety study
Journal of Gastrointestinal Oncology
2026;
17
(2)
:46
.
(30 April 2026)
The prevalence of gastric intestinal metaplasia in the Saudi population: a single-tertiary center retrospective study
Journal of Gastrointestinal Oncology
2026;
17
(2)
:47
.
(30 April 2026)
Prognostic impact of low absolute skeletal muscle mass 6 months after gastrectomy for gastric cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2026;
17
(2)
:48
.
(30 April 2026)
Diagnostic value of mini-probe endoscopic ultrasound in preoperative tumor nodal (TN) staging of gastric cancer and analysis of factors influencing T-staging accuracy
Journal of Gastrointestinal Oncology
2026;
17
(2)
:49
.
(30 April 2026)
Transcatheter arterial embolization with N-butyl cyanoacrylate versus gelatin sponge particles for gastric cancer-related upper gastrointestinal bleeding: a comparison of efficacy and safety
Journal of Gastrointestinal Oncology
2026;
17
(2)
:50
.
(30 April 2026)
Postoperative frailty among elderly patients undergoing radical surgery for gastrointestinal tumors and its relationship with prognosis
Journal of Gastrointestinal Oncology
2026;
17
(2)
:51
.
(30 April 2026)
Molecular characteristics and metastatic mechanism of patients diagnosed with Krukenberg tumor from gastric cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:52
.
(30 April 2026)
Retrospective study on clinical outcomes and safety evaluation of da Vinci robot-assisted laparoscopy and endoscopic cooperative for small gastric stromal tumors resection: preliminary single-center experience
Journal of Gastrointestinal Oncology
2026;
17
(2)
:53
.
(30 April 2026)
The impact of ulinastatin on postoperative clinical outcomes in patients with gastric cancer: a retrospective cohort analysis
Journal of Gastrointestinal Oncology
2026;
17
(2)
:54
.
(30 April 2026)
Comparison of the efficacy and safety of single-incision versus multi-port laparoscopic D2 lymphadenectomy for locally advanced gastric cancer: a systematic review and meta-analysis
Journal of Gastrointestinal Oncology
2026;
17
(2)
:55
.
(30 April 2026)
Development and external validation of a prognostic nomogram for cancer-specific survival in elderly patients with early-stage gastric cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:56
.
(30 April 2026)
Identification of immunogenic cell death-related prognostic genes in gastric cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:57
.
(30 April 2026)
Opportunistic CT screening for osteosarcopenia predicts reduced overall survival in patients with gastric cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2026;
17
(2)
:58
.
(30 April 2026)
Patterns of recurrence and outcomes of poor responders to neoadjuvant long-course chemoradiotherapy for rectal cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:59
.
(30 April 2026)
Identification of an autophagy-related prognostic signature and validation of WDR45 in colorectal cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:60
.
(30 April 2026)
KRAS mutation subtypes refine prognostic stratification in colorectal cancer: a retrospective cohort study
Journal of Gastrointestinal Oncology
2026;
17
(2)
:61
.
(30 April 2026)
Development and validation of manganese metabolism-related genes prognostic model in colorectal cancer and its immunological characteristics
Journal of Gastrointestinal Oncology
2026;
17
(2)
:62
.
(30 April 2026)
Intratumoral PKM2 expression predicts benefit from adjuvant FOLFOX in stage II–III colorectal cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:63
.
(30 April 2026)
Assessment of colorectal cancer recurrence risk following solid organ transplantation
Journal of Gastrointestinal Oncology
2026;
17
(2)
:64
.
(30 April 2026)
CCL5 promotes colon cancer progression via PI3K/AKT signaling and is negatively regulated by STAT1
Journal of Gastrointestinal Oncology
2026;
17
(2)
:65
.
(30 April 2026)
Molecular subtyping and prognostic model construction based on endosome-related genes in colorectal cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:66
.
(30 April 2026)
No survival benefit from adjuvant chemotherapy in high-risk stage II small intestinal adenocarcinoma after surgery: a population-based long-term survival analysis
Journal of Gastrointestinal Oncology
2026;
17
(2)
:67
.
(30 April 2026)
Transarterial embolization combined with octreotide long-acting release in treating rectal neuroendocrine tumor liver metastases: a single-institutional experience
Journal of Gastrointestinal Oncology
2026;
17
(2)
:68
.
(30 April 2026)
Single-cell transcriptome analysis identifies neutrophil-related prognostic signatures in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2026;
17
(2)
:69
.
(30 April 2026)
TRNP1 regulates tumorigenesis and enhances immunotherapy response via c-Kit/STAT3 signaling in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2026;
17
(2)
:70
.
(30 April 2026)
Perioperative clinicopathologic model for predicting 12-month early recurrence after curative hepatectomy in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2026;
17
(2)
:71
.
(30 April 2026)
Association of serum lactate dehydrogenase levels with the severity of microvascular invasion in hepatocellular carcinoma: a retrospective cross-sectional study
Journal of Gastrointestinal Oncology
2026;
17
(2)
:72
.
(30 April 2026)
An exploratory nomogram model with 18F-FDG PET/CT metabolic parameters for predicting high-risk status of microvascular invasion in hepatocellular carcinoma patients prior to liver transplantation
Journal of Gastrointestinal Oncology
2026;
17
(2)
:73
.
(30 April 2026)
Impact of tumor mutation burden on the prognosis of patients with unresectable hepatocellular carcinoma undergoing transcatheter arterial chemoembolization combined with immunotherapy and anti-angiogenic drugs
Journal of Gastrointestinal Oncology
2026;
17
(2)
:74
.
(30 April 2026)
Prognostic genes in hepatocellular carcinoma and their function: an analysis integrating high-throughput-based spatial transcriptomics and single-cell RNA-sequencing
Journal of Gastrointestinal Oncology
2026;
17
(2)
:75
.
(30 April 2026)
PD-1 inhibitors combined with tyrosine kinase inhibitors for conversion therapy in patients with unresectable hepatocellular carcinoma: a retrospective cohort study
Journal of Gastrointestinal Oncology
2026;
17
(2)
:76
.
(30 April 2026)
Development and validation of a model for predicting short-term complications after hepatectomy in patients with primary liver cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:77
.
(30 April 2026)
Temporal change in liver function after stereotactic body radiation therapy for hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2026;
17
(2)
:78
.
(30 April 2026)
A novel deep learning and radiomics approach based on DCE-MRI for predicting the P53 mutation status in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2026;
17
(2)
:79
.
(30 April 2026)
Peripheral regulatory T cells trajectory predicts progression-free survival in hepatocellular carcinoma patients during on-demand transarterial chemoembolization using joint model: a prospective study
Journal of Gastrointestinal Oncology
2026;
17
(2)
:80
.
(30 April 2026)
PD-1/PD-L1 expression and predictive value of efficacy in hepatocellular carcinoma patients with anti-PD-1 therapy: a real-world study
Journal of Gastrointestinal Oncology
2026;
17
(2)
:81
.
(30 April 2026)
Indeterminate nodule-like arterial phase hyperenhancement in the liver on CT: differentiation of hepatocellular carcinomas from vascular pseudolesions using a CT radiomics approach
Journal of Gastrointestinal Oncology
2026;
17
(2)
:82
.
(30 April 2026)
Association between primary tumor resection and survival in metastatic intrahepatic cholangiocarcinoma: a retrospective cohort study based on the SEER database
Journal of Gastrointestinal Oncology
2026;
17
(2)
:83
.
(30 April 2026)
Multi-scale deep learning models based on MRI for predicting pathological differentiation and evaluating its association with recurrence-free survival in hepatocellular carcinoma: an explainable machine learning study
Journal of Gastrointestinal Oncology
2026;
17
(2)
:84
.
(30 April 2026)
Daily increment of residual liver regeneration (DIRER) predicts tumor recurrence and mortality after radical hepatectomy for hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2026;
17
(2)
:85
.
(30 April 2026)
Silencing OTUB1 induces pyroptosis to inhibit the growth of liver cancer HepG2 cells via the NLRP3/caspase/GSDM signaling pathway
Journal of Gastrointestinal Oncology
2026;
17
(2)
:86
.
(30 April 2026)
Targeting AKR1C1 overcomes lenvatinib resistance in hepatocellular carcinoma through the STAT3-ABC transporters pathway
Journal of Gastrointestinal Oncology
2026;
17
(2)
:87
.
(30 April 2026)
Multi-institutional care is associated with improved survival in biliary tract cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:88
.
(30 April 2026)
Development and validation of machine learning models integrating spectral computed tomography-derived three-dimensional quantitative parameters for predicting histopathological grade in pancreatic ductal adenocarcinoma
Journal of Gastrointestinal Oncology
2026;
17
(2)
:89
.
(30 April 2026)
A biomarker-integrated nomogram for predicting postoperative pancreatic fistula in low- to intermediate-risk patients after pancreaticoduodenectomy
Journal of Gastrointestinal Oncology
2026;
17
(2)
:90
.
(30 April 2026)
Impact of preoperative body weight on short-term and long-term prognosis after pancreatic resection for pancreatic ductal adenocarcinoma: a multicenter study
Journal of Gastrointestinal Oncology
2026;
17
(2)
:91
.
(30 April 2026)
A TRPM4-associated necrotic cell death signature for prognostic stratification in pancreatic cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:92
.
(30 April 2026)
Single-nucleus RNA sequencing reveals the effects of key regulators on human pancreatic adenocarcinoma and its tumor microenvironment
Journal of Gastrointestinal Oncology
2026;
17
(2)
:93
.
(30 April 2026)
Neoadjuvant radiotherapy after chemotherapy does not improve surgical or survival outcomes in borderline resectable pancreatic cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:94
.
(30 April 2026)
Review Article
A systematic review of artificial intelligence and machine learning for gut microbiome-based CRC screening
Journal of Gastrointestinal Oncology
2026;
17
(2)
:95
.
(30 April 2026)
Multimodal data-driven prediction of postoperative recurrence and survival in hepatocellular carcinoma: a narrative review
Journal of Gastrointestinal Oncology
2026;
17
(2)
:96
.
(30 April 2026)
Risk factors for exclusive lung metastasis in colorectal cancer: a comprehensive narrative review
Journal of Gastrointestinal Oncology
2026;
17
(2)
:97
.
(30 April 2026)
Advances in mitophagy research in hepatocellular carcinoma: mechanisms and therapeutic implications
Journal of Gastrointestinal Oncology
2026;
17
(2)
:98
.
(30 April 2026)
Case Report
A case report of rectal squamous cell carcinoma following radiation therapy for prostate cancer: a management dilemma
Journal of Gastrointestinal Oncology
2026;
17
(2)
:99
.
(30 April 2026)
Diagnostic challenges in gastrointestinal stromal tumors: a case report of concurrent gastrointestinal stromal tumor, lymphangioma, and solid pseudopapillary neoplasm of the pancreas
Journal of Gastrointestinal Oncology
2026;
17
(2)
:100
.
(30 April 2026)
Brain metastasis from KRAS wild-type pancreatic cancer and organoid correlates: a case report
Journal of Gastrointestinal Oncology
2026;
17
(2)
:101
.
(30 April 2026)
Gastric lymphoma presenting with predominant pancreatitis and cranial neuropathy: a rare clinical presentation—a case report
Journal of Gastrointestinal Oncology
2026;
17
(2)
:102
.
(30 April 2026)
A case report of gastroesophageal adenocarcinoma with yolk sac tumor differentiation in a pregnant patient
Journal of Gastrointestinal Oncology
2026;
17
(2)
:103
.
(30 April 2026)
Letter to the Editor
The underestimated global burden and projections of early-onset stomach and early-onset esophageal cancers
Journal of Gastrointestinal Oncology
2026;
17
(2)
:104
.
(30 April 2026)
Impact of maintenance therapy with fluoropyrimidines in advanced esophageal-gastric adenocarcinoma: a critical review
Journal of Gastrointestinal Oncology
2026;
17
(2)
:105
.
(30 April 2026)
Methodological clarifications on maintenance fluoropyrimidines in advanced esophagogastric adenocarcinoma: a real-world Mexican cohort
Journal of Gastrointestinal Oncology
2026;
17
(2)
:106
.
(30 April 2026)
Fruquintinib in refractory metastatic colorectal cancer: separating randomized trial evidence from observational data
Journal of Gastrointestinal Oncology
2026;
17
(2)
:107
.
(30 April 2026)
Interpreting the evidence base for fruquintinib in refractory metastatic colorectal cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:108
.
(30 April 2026)
Editorial Commentary
Biomarker-guided immuno-angiogenic therapy in biliary tract cancer: insights from IMbrave151
Journal of Gastrointestinal Oncology
2026;
17
(2)
:109
.
(30 April 2026)
Personalised neoadjuvant therapy, based on tumour characteristics and patient choice, is the best way forward in rectal cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:110
.
(30 April 2026)
Is FOLFIRINOX more effective than gemcitabine plus nab-paclitaxel in pancreatic adenocarcinoma? —a decade of debate!
Journal of Gastrointestinal Oncology
2026;
17
(2)
:111
.
(30 April 2026)
Emerging mechanisms of kinase inhibitor escape and clinical implications of ponatinib in advanced gastrointestinal stromal tumor
Journal of Gastrointestinal Oncology
2026;
17
(2)
:112
.
(30 April 2026)
When precision medicine meets human behavior: limits of artificial intelligence in predicting imatinib adherence
Journal of Gastrointestinal Oncology
2026;
17
(2)
:113
.
(30 April 2026)
Anlotinib plus penpulimab: a new contender in first-line therapy for unresectable hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2026;
17
(2)
:114
.
(30 April 2026)
Muscling in on body surface area to reduce oxaliplatin-induced peripheral neuropathy in colon cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:115
.
(30 April 2026)
Clearing the bar: adding anti-VEGF therapy to chemoimmunotherapy for biliary tract cancer
Journal of Gastrointestinal Oncology
2026;
17
(2)
:116
.
(30 April 2026)
Editorial
Maximizing the “toolbox” for patients with initially unresectable colorectal liver metastases: have liver mets “met” their match?
Journal of Gastrointestinal Oncology
2026;
17
(2)
:117
.
(30 April 2026)
The 12-node rule in irradiated rectal cancer: time for reappraisal?
Journal of Gastrointestinal Oncology
2026;
17
(2)
:118
.
(30 April 2026)
Beyond drug toxicity: the hidden burden of financial toxicity in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2026;
17
(2)
:119
.
(30 April 2026)
Gastrointestinal malignancies in pregnancy: practical considerations
Journal of Gastrointestinal Oncology
2026;
17
(2)
:120
.
(30 April 2026)
Intrahepatic cholangiocarcinoma: the equity gap in one of the most lethal cancers
Journal of Gastrointestinal Oncology
2026;
17
(2)
:121
.
(30 April 2026)
Adjuvant chemotherapy in elderly colon cancer patients: when less may be more
Journal of Gastrointestinal Oncology
2026;
17
(2)
:122
.
(30 April 2026)
Sarcopenia in esophageal cancer: from passive prognostic marker to active treatment target
Journal of Gastrointestinal Oncology
2026;
17
(2)
:123
.
(30 April 2026)
Return on investment, return of risk: private equity in gastrointestinal cancer care
Journal of Gastrointestinal Oncology
2026;
17
(2)
:124
.
(30 April 2026)
Tumor necrosis as a key refinement of risk stratification in gastric gastrointestinal stromal tumors
Journal of Gastrointestinal Oncology
2026;
17
(2)
:125
.
(30 April 2026)
Survival outcomes in early gastric cancer: evidence from SEER-based population studies
Journal of Gastrointestinal Oncology
2026;
17
(2)
:126
.
(30 April 2026)
Spontaneous rupture of hepatocellular carcinoma: mechanobiology, rescue, and oncologic control
Journal of Gastrointestinal Oncology
2026;
17
(2)
:127
.
(30 April 2026)
From waste to wealth: malignant ascites-derived organoids as a compass for precision therapy in advanced gastrointestinal cancers
Journal of Gastrointestinal Oncology
2026;
17
(2)
:128
.
(30 April 2026)
Erratum
Erratum: Efficacy and safety of dose adjustment for fruquintinib in the third-line treatment of metastatic colorectal cancer: a retrospective study with real-world settings
Journal of Gastrointestinal Oncology
2026;
17
(2)
:129
.
(30 April 2026)
Retraction
Retraction: Interfering HMGB3 release from cancer-associated fibroblasts by miR-200b represses chemoresistance and epithelial-mesenchymal transition of gastric cancer cells
Journal of Gastrointestinal Oncology
2026;
17
(2)
:130
.
(30 April 2026)
